Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 16,279 followers.

RT @Myeloma_Doc: Decitabine shows potent anti-myeloma activity pre-clinically by depleting monocytic myeloid-derived suppressor cells in th…

RT @Myeloma_Doc: Decitabine shows potent anti-myeloma activity pre-clinically by depleting monocytic myeloid-derived suppressor cells in th…

Decitabine shows potent anti-myeloma activity pre-clinically by depleting monocytic myeloid-derived suppressor cells in the #myeloma microenvironment: https://t.co/VHz5c46S6e. https://t.co/yQZRU1emyU